164 related articles for article (PubMed ID: 34332175)
1. Airway Hyperresponsiveness to Inhaled Mannitol Identifies a Cluster of Noneosinophilic Asthma Patients with High Symptom Burden.
Sverrild A; Andreasen AH; Westergaard CG; von Bülow A; Udesen PB; Thomsen SF; Allin KH; Backer V; Porsbjerg C
J Allergy Clin Immunol Pract; 2021 Nov; 9(11):4029-4036.e2. PubMed ID: 34332175
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO.
Porsbjerg C; Lund TK; Pedersen L; Backer V
J Asthma; 2009 Aug; 46(6):606-12. PubMed ID: 19657904
[TBL] [Abstract][Full Text] [Related]
3. Airway hyperresponsiveness correlates with airway TSLP in asthma independent of eosinophilic inflammation.
Andreasson LM; Dyhre-Petersen N; Hvidtfeldt M; Jørgensen GØ; Von Bülow A; Klein DK; Uller L; Erjefält J; Porsbjerg C; Sverrild A
J Allergy Clin Immunol; 2024 Apr; 153(4):988-997.e11. PubMed ID: 38081546
[TBL] [Abstract][Full Text] [Related]
4. Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients.
Porsbjerg C; Brannan JD; Anderson SD; Backer V
Clin Exp Allergy; 2008 Jan; 38(1):43-50. PubMed ID: 18028458
[TBL] [Abstract][Full Text] [Related]
5. Eosinophilic airway inflammation in asthmatic patients is associated with an altered airway microbiome.
Sverrild A; Kiilerich P; Brejnrod A; Pedersen R; Porsbjerg C; Bergqvist A; Erjefält JS; Kristiansen K; Backer V
J Allergy Clin Immunol; 2017 Aug; 140(2):407-417.e11. PubMed ID: 28042058
[TBL] [Abstract][Full Text] [Related]
6. Airway hyperresponsiveness to mannitol improves in both type 2 high and type 2 low asthma after specialist management.
Hvidtfeldt M; Sverrild A; Backer V; Porsbjerg C
J Asthma; 2021 Sep; 58(9):1221-1228. PubMed ID: 32519918
[TBL] [Abstract][Full Text] [Related]
7. Airway responsiveness to mannitol in asthma is associated with chymase-positive mast cells and eosinophilic airway inflammation.
Sverrild A; Bergqvist A; Baines KJ; Porsbjerg C; Andersson CK; Thomsen SF; Hoffmann HJ; Gibson P; Erjefält JS; Backer V
Clin Exp Allergy; 2016 Feb; 46(2):288-97. PubMed ID: 26252943
[TBL] [Abstract][Full Text] [Related]
8. Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide in children with asthma.
Park YA; Park HB; Kim YH; Sul IS; Yoon SH; Kim HR; Kim KW; Kim KE; Sohn MH
J Asthma; 2017 Aug; 54(6):644-651. PubMed ID: 28055271
[TBL] [Abstract][Full Text] [Related]
9. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes.
Lemière C; Ernst P; Olivenstein R; Yamauchi Y; Govindaraju K; Ludwig MS; Martin JG; Hamid Q
J Allergy Clin Immunol; 2006 Nov; 118(5):1033-9. PubMed ID: 17088126
[TBL] [Abstract][Full Text] [Related]
10. FENO and AHR mannitol in patients referred to an out-of-hospital asthma clinic: a real-life study.
Backer V; Sverrild A; Porsbjerg C
J Asthma; 2014 May; 51(4):411-6. PubMed ID: 24450977
[TBL] [Abstract][Full Text] [Related]
11. Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma.
Leuppi JD; Salome CM; Jenkins CR; Koskela H; Brannan JD; Anderson SD; Andersson M; Chan HK; Woolcock AJ
Eur Respir J; 2001 Sep; 18(3):444-50. PubMed ID: 11589340
[TBL] [Abstract][Full Text] [Related]
12. Eosinophilic airway inflammation is a main feature of unstable asthma in adolescents.
Ciółkowski J; Emeryk A; Hydzik P; Emeryk-Maksymiuk J; Kosmala E; Stasiowska B
Respir Med; 2019 Feb; 147():7-12. PubMed ID: 30704702
[TBL] [Abstract][Full Text] [Related]
13. Airway hyperresponsiveness reflects corticosteroid-sensitive mast cell involvement across asthma phenotypes.
Hvidtfeldt M; Sverrild A; Pulga A; Frøssing L; Silberbrandt A; Hostrup M; Thomassen M; Sanden C; Clausson CM; Siddhuraj P; Bornesund D; Nieto-Fontarigo JJ; Uller L; Erjefält J; Porsbjerg C
J Allergy Clin Immunol; 2023 Jul; 152(1):107-116.e4. PubMed ID: 36907566
[TBL] [Abstract][Full Text] [Related]
14. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma.
van Rensen EL; Straathof KC; Veselic-Charvat MA; Zwinderman AH; Bel EH; Sterk PJ
Thorax; 1999 May; 54(5):403-8. PubMed ID: 10212103
[TBL] [Abstract][Full Text] [Related]
15. Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis.
Petsky HL; Cates CJ; Kew KM; Chang AB
Thorax; 2018 Dec; 73(12):1110-1119. PubMed ID: 29858277
[TBL] [Abstract][Full Text] [Related]
16. Mannitol versus hypertonic saline: Safety and efficacy of mannitol and hypertonic saline in sputum induction and bronchial hyperreactivity assessment.
Alvarez-Puebla MJ; Olaguibel JM; Almudevar E; Echegoyen AA; Vela C; de Esteban B
Chron Respir Dis; 2015 Aug; 12(3):197-203. PubMed ID: 25761367
[TBL] [Abstract][Full Text] [Related]
17. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids.
Leuppi JD; Salome CM; Jenkins CR; Anderson SD; Xuan W; Marks GB; Koskela H; Brannan JD; Freed R; Andersson M; Chan HK; Woolcock AJ
Am J Respir Crit Care Med; 2001 Feb; 163(2):406-12. PubMed ID: 11179114
[TBL] [Abstract][Full Text] [Related]
18. Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.
Heaney LG; Perez de Llano L; Al-Ahmad M; Backer V; Busby J; Canonica GW; Christoff GC; Cosio BG; FitzGerald JM; Heffler E; Iwanaga T; Jackson DJ; Menzies-Gow AN; Papadopoulos NG; Papaioannou AI; Pfeffer PE; Popov TA; Porsbjerg CM; Rhee CK; Sadatsafavi M; Tohda Y; Wang E; Wechsler ME; Alacqua M; Altraja A; Bjermer L; Björnsdóttir US; Bourdin A; Brusselle GG; Buhl R; Costello RW; Hew M; Koh MS; Lehmann S; Lehtimäki L; Peters M; Taillé C; Taube C; Tran TN; Zangrilli J; Bulathsinhala L; Carter VA; Chaudhry I; Eleangovan N; Hosseini N; Kerkhof M; Murray RB; Price CA; Price DB
Chest; 2021 Sep; 160(3):814-830. PubMed ID: 33887242
[TBL] [Abstract][Full Text] [Related]
19. Combining the Mannitol Test and FeNO in the Assessment of Poorly Controlled Asthma.
Porsbjerg C; Sverrild A; Backer V
J Allergy Clin Immunol Pract; 2015; 3(4):553-9. PubMed ID: 25824441
[TBL] [Abstract][Full Text] [Related]
20. The Combined Impact of Exhaled Nitric Oxide and Sputum Eosinophils Monitoring in Asthma Treatment: A Prospective Cohort Study.
Malerba M; Radaeli A; Olivini A; Ragnoli B; Ricciardolo F; Montuschi P
Curr Pharm Des; 2015; 21(32):4752-62. PubMed ID: 26166613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
